{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:22:38Z","timestamp":1790266958047,"version":"4.1.0"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T00:00:00Z","timestamp":1584489600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ES025534"],"award-info":[{"award-number":["ES025534"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL062410"],"award-info":[{"award-number":["HL062410"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL102245"],"award-info":[{"award-number":["HL102245"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2020.00474","type":"journal-article","created":{"date-parts":[[2020,3,18]],"date-time":"2020-03-18T04:34:19Z","timestamp":1584506059000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Adaptive Immunity in Pulmonary Sarcoidosis and Chronic Beryllium Disease"],"prefix":"10.3389","volume":"11","author":[{"given":"Sarah A.","family":"Greaves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikh M.","family":"Atif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P.","family":"Fontenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,3,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"170012","DOI":"10.1183\/16000617.0012-2017","article-title":"Differential diagnosis of granulomatous lung disease: clues and pitfalls: number 4 in the Series \u201cPathology for the clinician\u201d Edited by Peter Dorfmuller and Alberto Cavazza","volume":"26","author":"Ohshimo","year":"2017","journal-title":"Eur Respir Rev."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1164\/ajrccm\/139.6.1479","article-title":"Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history","volume":"139","author":"Newman","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4081\/mrm.2012.598","article-title":"The sarcoid granuloma: \u2018epithelioid' or 'lymphocytic-epithelioid' granuloma?","volume":"7","author":"Kosjerina","year":"2012","journal-title":"Multidiscip Respir Med."},{"key":"B5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/2040622318790197","article-title":"Epidemiology of sarcoidosis: current findings and future directions","volume":"9","author":"Arkema","year":"2018","journal-title":"Ther Adv Chronic Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1080\/15459620490502233","article-title":"Industries in the United States with airborne beryllium exposure and estimates of the number of current workers potentially exposed","volume":"1","author":"Henneberger","year":"2004","journal-title":"J Occup Environ Hyg."},{"key":"B7","first-page":"197","article-title":"Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds","volume":"28","author":"Hardy","year":"1946","journal-title":"J Ind Hyg Toxicol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0013-9351(82)90059-7","article-title":"Origins of the standards for control of beryllium disease (1947-1949)","volume":"27","author":"Eisenbud","year":"1982","journal-title":"Environ Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/nrrheum.2011.93","article-title":"Sarcoidosis\u2013scientific progress and clinical challenges","volume":"7","author":"Chen","year":"2011","journal-title":"Nat Rev Rheumatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1164\/rccm.200402-190OC","article-title":"Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk","volume":"171","author":"Newman","year":"2005","journal-title":"Am J Respir Crit Care Med."},{"key":"B11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/(SICI)1097-0274(199710)32:4<337::AID-AJIM3>3.0.CO;2-R","article-title":"Interaction of genetic and exposure factors in the prevalence of berylliosis","volume":"32","author":"Richeldi","year":"1997","journal-title":"Am J Ind Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.1164\/rccm.201002-0254OC","article-title":"Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers","volume":"183","author":"Van Dyke","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1289\/ehp.96104s5937","article-title":"The natural history of beryllium sensitization and chronic beryllium disease","volume":"104","author":"Newman","year":"1996","journal-title":"Environ Health Perspect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1126\/science.8105536","article-title":"HLA-DPB1 glutamate 69: a genetic marker of beryllium disease","volume":"262","author":"Richeldi","year":"1993","journal-title":"Science."},{"key":"B15","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.4049\/jimmunol.163.3.1647","article-title":"Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles","volume":"163","author":"Wang","year":"1999","journal-title":"J Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1086\/378097","article-title":"HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites","volume":"73","author":"Rossman","year":"2003","journal-title":"Am J Hum Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1586\/eci.11.76","article-title":"HLA associations and L\u00f6fgren's syndrome","volume":"8","author":"Grunewald","year":"2012","journal-title":"Expert Rev Clin Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"351852","DOI":"10.1155\/2014\/351852","article-title":"The prevalence of antinuclear antibodies in patients with sarcoidosis","volume":"2014","author":"Kobak","year":"2014","journal-title":"Autoimmune Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fimmu.2018.01516","article-title":"In situ humoral immunity to vimentin in HLA-DRB1*03+ patients with pulmonary sarcoidosis","volume":"9","author":"Kinloch","year":"2018","journal-title":"Front Immunol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"125494","DOI":"10.1172\/jci.insight.125494","article-title":"Protective role of B cells in sterile particulate-induced lung injury","volume":"5","author":"Atif","year":"2019","journal-title":"JCI Insight."},{"key":"B21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1164\/rccm.2210007","article-title":"Alveolar macrophages: wielding the double-edged sword of inflammation","volume":"167","author":"Rubins","year":"2003","journal-title":"Am J Respir Crit Care Med."},{"key":"B22","unstructured":"Alterations in the membrane-associated proteome fraction of alveolar macrophages in sarcoidosis1728 KjellinH SilvaE BrancaRM EklundA JakobssonPJ GrunewaldJ 27055832Sarcoidosis Vasc Diffuse Lung Dis.332016"},{"key":"B23","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.humimm.2012.05.005","article-title":"Changed phagocytic activity and pattern of Fcgamma and complement receptors on blood monocytes in sarcoidosis","volume":"73","author":"Dubaniewicz","year":"2012","journal-title":"Hum Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s10875-008-9225-0","article-title":"Higher monocyte expression of TLR2 and TLR4, and enhanced pro-inflammatory synergy of TLR2 with NOD2 stimulation in sarcoidosis","volume":"29","author":"Wiken","year":"2009","journal-title":"J Clin Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/cei.12138","article-title":"Disordered Toll-like receptor 2 responses in the pathogenesis of pulmonary sarcoidosis","volume":"173","author":"Gabrilovich","year":"2013","journal-title":"Clin Exp Immunol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1378\/chest.12-0383","article-title":"Nicotine treatment improves Toll-like receptor 2 and Toll-like receptor 9 responsiveness in active pulmonary sarcoidosis","volume":"143","author":"Julian","year":"2013","journal-title":"Chest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"B29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cell.2019.11.026","article-title":"Serum amyloid A proteins induce pathogenic Th17 cells and promote inflammatory disease","volume":"180","author":"Lee","year":"2020","journal-title":"Cell."},{"key":"B30","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1007\/s11033-013-2513-7","article-title":"Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study","volume":"40","author":"Daniil","year":"2013","journal-title":"Mol Biol Rep."},{"key":"B31","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4049\/jimmunol.134.4.2047","article-title":"The effects of beryllium and other adjuvants on Ia expression by macrophages","volume":"134","author":"Behbehani","year":"1985","journal-title":"J Immunol."},{"key":"B32","first-page":"345","article-title":"Studies on the adjuvant action of beryllium. IV The preparation of beryllium containing macromolecules that induce immunoblast responses in vivo","volume":"64","author":"Hall","year":"1988","journal-title":"Immunology."},{"key":"B33","first-page":"341","article-title":"Studies on the adjuvant action of beryllium. III The activity in the plasma of lymph efferent from nodes stimulated with beryllium","volume":"64","author":"Denham","year":"1988","journal-title":"Immunology."},{"key":"B34","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1128\/IAI.68.7.4032-4039.2000","article-title":"Beryllium, an adjuvant that promotes gamma interferon production","volume":"68","author":"Lee","year":"2000","journal-title":"Infect Immun."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1183\/09031936.02.02232001","article-title":"HLA-DP-unrestricted TNF-alpha release in beryllium-stimulated peripheral blood mononuclear cells","volume":"20","author":"Amicosante","year":"2002","journal-title":"Eur Respir J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.tox.2005.10.016","article-title":"Chemokine regulation in response to beryllium exposure in human peripheral blood mononuclear and dendritic cells","volume":"218","author":"Hong-Geller","year":"2006","journal-title":"Toxicology."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/mi.2015.14","article-title":"MyD88 dependence of beryllium-induced dendritic cell trafficking and CD4+ T-cell priming","volume":"8","author":"McKee","year":"2015","journal-title":"Mucosal Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.4049\/jimmunol.1800303","article-title":"TLR9 and IL-1R1 promote mobilization of pulmonary dendritic cells during beryllium sensitization","volume":"201","author":"Wade","year":"2018","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1172\/JCI110036","article-title":"Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes","volume":"67","author":"Hunninghake","year":"1981","journal-title":"J Clin Invest."},{"key":"B40","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am J Respir Crit Care Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1172\/JCI32401","article-title":"Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis","volume":"117","author":"Wahlstrom","year":"2007","journal-title":"J Clin Invest."},{"key":"B42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1056\/NEJM198108203050804","article-title":"Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity","volume":"305","author":"Hunninghake","year":"1981","journal-title":"N Engl J Med."},{"key":"B43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.7326\/0003-4819-108-5-687","article-title":"Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease","volume":"108","author":"Rossman","year":"1988","journal-title":"Ann Intern Med"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1056\/NEJM198904273201702","article-title":"Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells","volume":"320","author":"Saltini","year":"1989","journal-title":"N Engl J Med."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1084\/jem.171.4.1123","article-title":"Biased accumulation of T lymphocytes with \u201cmemory\u201d-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung","volume":"171","author":"Saltini","year":"1990","journal-title":"J Exp Med."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.4049\/jimmunol.163.2.1019","article-title":"Identification of pathogenic T cells in patients with beryllium-induced lung disease","volume":"163","author":"Fontenot","year":"1999","journal-title":"J Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1513\/pats.200606-130MS","article-title":"Role of CD4+ T cells in sarcoidosis","volume":"4","author":"Grunewald","year":"2007","journal-title":"Proc Am Thorac Soc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1172\/JCI0215846","article-title":"Target organ localization of memory CD4+ T cells in patients with chronic beryllium disease","volume":"110","author":"Fontenot","year":"2002","journal-title":"J Clin Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1172\/JCI200318317","article-title":"CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells","volume":"112","author":"Fontenot","year":"2003","journal-title":"J Clin Invest."},{"key":"B50","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4049\/jimmunol.158.1.518","article-title":"Beryllium induces IL-2 and IFN-gamma in berylliosis","volume":"158","author":"Tinkle","year":"1997","journal-title":"J Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/BF00183946","article-title":"Increased interleukin 6 production by bronchoalveolar lavage cells in patients with active sarcoidosis","volume":"171","author":"Homolka","year":"1993","journal-title":"Lung."},{"key":"B52","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1159\/000236532","article-title":"Effect of GM-CSF on TNF-alpha and IL-1-beta production by alveolar macrophages and peripheral blood monocytes from patients with sarcoidosis","volume":"102","author":"Terao","year":"1993","journal-title":"Int Arch Allergy Immunol."},{"key":"B53","doi-asserted-by":"crossref","first-page":"4952","DOI":"10.4049\/jimmunol.156.12.4952","article-title":"Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis","volume":"156","author":"Moller","year":"1996","journal-title":"J Immunol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"e9088","DOI":"10.1371\/annotation\/a75007e1-492a-4bcb-80a8-28b4d432c099","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS ONE"},{"key":"B55","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-gamma-producing T-helper 17","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am J Respir Crit Care Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"170112","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur Respir J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5446","DOI":"10.4049\/jimmunol.1202891","article-title":"Reversal of global CD4+ subset dysfunction is associated with spontaneous clinical resolution of pulmonary sarcoidosis","volume":"190","author":"Oswald-Richter","year":"2013","journal-title":"J Immunol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"3642832","DOI":"10.1155\/2017\/3642832","article-title":"Local and systemic CD4+ T cell exhaustion reverses with clinical resolution of pulmonary sarcoidosis","volume":"2017","author":"Hawkins","year":"2017","journal-title":"J Immunol Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The diverse functions of the PD1 inhibitory pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat Rev Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"eaar8356","DOI":"10.1126\/scitranslmed.aar8356","article-title":"PD-1 up-regulation on CD4+ T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-beta1 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci Transl Med."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.4049\/jimmunol.180.4.2704","article-title":"Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease","volume":"180","author":"Palmer","year":"2008","journal-title":"J Immunol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.4049\/jimmunol.1300282","article-title":"Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation","volume":"191","author":"Chain","year":"2013","journal-title":"J Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"e34","DOI":"10.1164\/rccm.201409-1722ST","article-title":"An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease","volume":"190","author":"Balmes","year":"2014","journal-title":"Am J Respir Crit Care Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1164\/ajrccm.165.6.2104002","article-title":"Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity","volume":"165","author":"Rossman","year":"2002","journal-title":"Am J Respir Crit Care Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"6910","DOI":"10.4049\/jimmunol.171.12.6910","article-title":"Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease","volume":"171","author":"Maier","year":"2003","journal-title":"J Immunol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"4014","DOI":"10.4049\/jimmunol.1200798","article-title":"Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove","volume":"189","author":"Silveira","year":"2012","journal-title":"J Immunol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"B69","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1513\/pats.200607-141JG","article-title":"Genetics of sarcoidosis: candidate genes and genome scans","volume":"4","author":"Iannuzzi","year":"2007","journal-title":"Proc Am Thorac Soc."},{"key":"B70","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"L\u00f6fgren's syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1126\/science.3317824","article-title":"The T cell receptor","volume":"238","author":"Marrack","year":"1987","journal-title":"Science."},{"key":"B72","doi-asserted-by":"publisher","first-page":"7425","DOI":"10.1073\/pnas.1001772107","article-title":"Crystal structure of HLA-DP2 and implications for chronic beryllium disease","volume":"107","author":"Dai","year":"2010","journal-title":"Proc Natl Acad Sci USA."},{"key":"B73","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.cell.2014.04.048","article-title":"Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity","volume":"158","author":"Clayton","year":"2014","journal-title":"Cell."},{"key":"B74","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1165\/ajrcmb.18.4.2981","article-title":"Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease","volume":"18","author":"Fontenot","year":"1998","journal-title":"Am J Respir Cell Mol Biol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"4571","DOI":"10.4049\/jimmunol.1400007","article-title":"Identification of multiple public TCR repertoires in chronic beryllium disease","volume":"192","author":"Bowerman","year":"2014","journal-title":"J Immunol."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1084\/jem.20122426","article-title":"Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease","volume":"210","author":"Falta","year":"2013","journal-title":"J Exp Med."},{"key":"B77","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1002\/eji.1830220120","article-title":"Restricted V alpha 2","volume":"22","author":"Grunewald","year":"1992","journal-title":"Eur J Immunol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.1073\/pnas.91.11.4965","article-title":"T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients","volume":"91","author":"Grunewald","year":"1994","journal-title":"Proc Natl Acad Sci USA."},{"key":"B79","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1164\/ajrccm.161.3.9906001","article-title":"Lung T-helper cells expressing T-cell receptor AV2S3 associate with clinical features of pulmonary sarcoidosis","volume":"161","author":"Grunewald","year":"2000","journal-title":"Am J Respir Crit Care Med."},{"key":"B80","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1183\/09031936.03.00059103","article-title":"Markers of activity in clinically recovered human leukocyte antigen-DR17-positive sarcoidosis patients","volume":"21","author":"Planck","year":"2003","journal-title":"Eur Respir J."},{"key":"B81","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.4049\/jimmunol.1700570","article-title":"Shared alphabeta TCR Usage in Lungs of Sarcoidosis Patients with L\u00f6fgren's Syndrome","volume":"199","author":"Mitchell","year":"2017","journal-title":"J Immunol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/ncb0804-699","article-title":"Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds","volume":"6","author":"Coulombe","year":"2004","journal-title":"Nat Cell Biol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1074\/mcp.M116.060764","article-title":"Approach for identifying human leukocyte antigen (HLA)-DR bound peptides from scarce clinical samples","volume":"15","author":"Heyder","year":"2016","journal-title":"Mol Cell Proteomics."},{"key":"B84","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1183\/09031936.00002607","article-title":"Molecular evidence for the role of mycobacteria in sarcoidosis: a meta-analysis","volume":"30","author":"Gupta","year":"2007","journal-title":"Eur Respir J."},{"key":"B85","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12890-016-0332-z","article-title":"Is there any association between Sarcoidosis and infectious agents?: a systematic review and meta-analysis","volume":"16","author":"Esteves","year":"2016","journal-title":"BMC Pulm Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"8784","DOI":"10.4049\/jimmunol.181.12.8784","article-title":"T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis","volume":"181","author":"Chen","year":"2008","journal-title":"J Immunol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.1128\/IAI.00142-09","article-title":"Cellular responses to mycobacterial antigens are present in bronchoalveolar lavage fluid used in the diagnosis of sarcoidosis","volume":"77","author":"Oswald-Richter","year":"2009","journal-title":"Infect Immun."},{"key":"B88","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J Exp Med."},{"key":"B89","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1128\/JCM.40.1.198-204.2002","article-title":"Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis","volume":"40","author":"Eishi","year":"2002","journal-title":"J Clin Microbiol."},{"key":"B90","first-page":"33","article-title":"Propionibacterium acnes is the most common bacterium commensal in peripheral lung tissue and mediastinal lymph nodes from subjects without sarcoidosis","volume":"22","author":"Ishige","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1111\/j.1742-1241.2006.00773.x","article-title":"Seasonal variation of the onset of presentations in stage 1 sarcoidosis","volume":"60","author":"Demirkok","year":"2006","journal-title":"Int J Clin Pract."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1378\/chest.06-2114","article-title":"World Trade Center \u201csarcoid-like\u201d granulomatous pulmonary disease in New York City Fire Department rescue workers","volume":"131","author":"Izbicki","year":"2007","journal-title":"Chest."},{"key":"B94","doi-asserted-by":"publisher","first-page":"e016839","DOI":"10.1136\/bmjopen-2017-016839","article-title":"Risk of sarcoidosis and seropositive rheumatoid arthritis from occupational silica exposure in Swedish iron foundries: a retrospective cohort study","volume":"7","author":"Vihlborg","year":"2017","journal-title":"BMJ Open."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00474\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T19:36:38Z","timestamp":1695929798000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2020.00474\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,18]]},"references-count":94,"alternative-id":["10.3389\/fimmu.2020.00474"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2020.00474","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,18]]},"article-number":"474"}}